Associate Director, CMC Lead

The Associate Director, CMC Lead leads early-stage CMC strategy for precision radioconjugate medicines, driving IND-enabling plans and establishing foundations for reliable clinical supply. This role involves steering development across a portfolio of alpha-emitting, tumor-targeted therapies while balancing scientific rigor with speed to de-risk the path to first-in-human studies. The position requires managing multiple early-stage programs, coordinating cross-functional teams, and ensuring phase-appropriate pharmaceutical development strategies.